iCo Therapeutics has announced that on 26 November 2013, US patent 8,592,382 was issued for the Oral Amphotericin B platform (Oral AmpB) providing protection around oral delivery of the drug. With the recent receipt of ethics approval, ...
Tags: iCo Therapeutics, Medicine